03.21.17
Merck launched the Mobius MyWay portfolio, a program designed to provide more flexibility, better supply predictability and shorter lead times for efficient and safe drug manufacture.
"We have the industry's only comprehensive single-use solution, giving customers three different ways to create customizable assemblies," said Andrew Bulpin, head of Process Solutions Strategic Marketing & Innovation at the life science business sector of Merck. "This is critical to customers from contract manufacturing organizations to big pharma, whose biggest challenge is getting custom assemblies with fast, reliable lead times for quicker turnarounds and more rapid biomanufacturing."
For commercial manufacturers, Mobius MyWay aims to help minimize schedule disruptions and delays. Pilot plants benefit from faster assembly design and delivery in order to adjust to new and evolving needs in real-time, according to the company, and contract manufacturing organizations can benefit from more reliable lead times for better planning to help ensure on-time product delivery.
Merck's portfolio offers a choice of off-the-shelf and configured-to-order assemblies, as well as customizable configurations. Assemblies available as part of the portfolio are used for safe and effective fluid management across upstream and downstream processes, from routine buffer and media prep, to critical premium aseptic process and final drug manufacturing.
Assemblies are segmented into three categories:
• Mobius Stock offers on-demand solutions ready to ship in 24 hours.
• Mobius Select offers a balance of speed and configurability of custom assemblies from an optimized component library with a 6-week lead time.
• Mobius Choice offers customized solutions from an expansive component library, shipped in standard lead times.
Among the assemblies included in the Mobius MyWay portfolio are Mobius MIX systems and bags up to 1,000 liters; holding and transport vessels up to 3,500 liters; Lynx CDR sterile connectors and single-use final formulation, filtration and final fill assemblies.
"We have the industry's only comprehensive single-use solution, giving customers three different ways to create customizable assemblies," said Andrew Bulpin, head of Process Solutions Strategic Marketing & Innovation at the life science business sector of Merck. "This is critical to customers from contract manufacturing organizations to big pharma, whose biggest challenge is getting custom assemblies with fast, reliable lead times for quicker turnarounds and more rapid biomanufacturing."
For commercial manufacturers, Mobius MyWay aims to help minimize schedule disruptions and delays. Pilot plants benefit from faster assembly design and delivery in order to adjust to new and evolving needs in real-time, according to the company, and contract manufacturing organizations can benefit from more reliable lead times for better planning to help ensure on-time product delivery.
Merck's portfolio offers a choice of off-the-shelf and configured-to-order assemblies, as well as customizable configurations. Assemblies available as part of the portfolio are used for safe and effective fluid management across upstream and downstream processes, from routine buffer and media prep, to critical premium aseptic process and final drug manufacturing.
Assemblies are segmented into three categories:
• Mobius Stock offers on-demand solutions ready to ship in 24 hours.
• Mobius Select offers a balance of speed and configurability of custom assemblies from an optimized component library with a 6-week lead time.
• Mobius Choice offers customized solutions from an expansive component library, shipped in standard lead times.
Among the assemblies included in the Mobius MyWay portfolio are Mobius MIX systems and bags up to 1,000 liters; holding and transport vessels up to 3,500 liters; Lynx CDR sterile connectors and single-use final formulation, filtration and final fill assemblies.
